Results 61 to 70 of about 20,467 (239)

Artificial Intelligence in Ophthalmology: Current Status, Challenges, and Future Perspectives

Health Care Science, EarlyView.
Current research of artificial intelligence (AI) in ophthalmology. ABSTRACT Artificial intelligence (AI) is revolutionizing ophthalmology by providing innovative solutions for disease screening, diagnosis, personalized treatment, and the delivery of global healthcare services.
She Chongyang, Tao Yong
wiley   +1 more source

Diabetic Retinopathy in Primary Healthcare in a Brazilian Municipality: A Cross‐Sectional Study Using Teleophthalmology

Health Care Science, EarlyView.
The prevalence of diabetic retinopathy was estimated to be 28.3% (95% CI 21.1–35.4), with most of the cases corresponding to mild non‐proliferative diabetic retinopathy. ABSTRACT Background Diabetic retinopathy is a complication of diabetes and the leading cause of irreversible blindness in people of working age.
Lorrana Luysse dos Anjos Assis, Fernando Korn Malerbi, Rosiane Chiaroti, Lívia Maria Ferrante Vizzotto Consoli, Vanessa Patrícia Pereira Motozo, Francisco Barbosa‐Junior, Rinaldo Eduardo Machado de Oliveira   +6 more
wiley   +1 more source

Interobserver agreement in detecting spectral-domain optical coherence tomography features of diabetic macular edema [PDF]

, 2015
Purpose: To evaluate interobserver agreement for the detection of spectral-domain optical coherence tomography (SDOCT) features of diabetic macular edema (DME). Method: Cross-sectional study in which 2 retinal specialists evaluated SDOCT scans from eyes
Heng, LZ, Hykin, P, Patel, PJ, Pefianaki, M   +3 more
core   +7 more sources

Quantifying burden of intravitreal injections: questionnaire assessment of life impact of treatment by intravitreal injections (QUALITII)

BMJ Open Ophthalmology, 2022
Aim To quantify the areas of burden experienced by patients requiring repeated intravitreal injections (IVI) in the management of exudative retinal diseases.Methods The validated Questionnaire to Assess Life Impact of Treatment by Intravitreal Injections
Rui Wang, David A Eichenbaum, Namrata Saroj, Carl Regillo, Charles Clifton Wykoff, Cynthia K McClard, Victoria Windham, Sagit Fried, Erik B Lehman, Mirataollah Salabati, Raziyeh Mahmoudzadeh, Stephen Laswell, Michael Ammar, Jordyn Vannavong, Aamir A Aziz, Amy Ewald, Allison V Calvanese, Adriana Strutt, Arshad Mohammad Khanani   +18 more
doaj   +1 more source

Berberine alleviates cell pyroptosis in diabetic retinopathy by regulating AKT1, JUN, and STAT3

Ibrain, EarlyView.
Berberine alleviates diabetic retinopathy by reducing pyroptosis through AKT1/JUN/STAT3 regulation, as validated in rat models via network pharmacology, molecular docking, and experimental assays. Abstract Berberine (BBR) exerts an effective protection for diabetic retinopathy (DR), but the underlying key molecular mechanism remains unknown; this study
Na Li, Ji‐Lin Chen, Yi‐Jian Sun, Jia‐Fan Sun, Fatin Athirah Pauzi, Song‐Lin Zhu, Amy Yi Hsan Saik, Alan Han‐Kiat Ong   +7 more
wiley   +1 more source

Hypertensive retinopathy in pre‐eclampsia and its association with disease severity and neonatal outcomes: A retrospective cohort study

International Journal of Gynecology &Obstetrics, EarlyView.
Abstract Introduction Pre‐eclampsia (PE) involves systemic endothelial dysfunction and microvascular injury, yet routine obstetric care lacks noninvasive readouts of maternal microvascular health. We evaluated whether hypertensive retinopathy (HR) detected during pregnancy is associated with maternal disease severity and adverse neonatal outcomes ...
Gabriele Saccone, Francesco Matarazzo, Mariarosaria Motta, Marika Rovetto, Michele Rinaldi, Maurizio Guida, Ciro Costagliola   +6 more
wiley   +1 more source

Anti-VEGF Therapy and the Retina: An Update

Journal of Ophthalmology, 2015
Ocular angiogenesis and macular oedema are major causes of sight loss across the world. Aberrant neovascularisation, which may arise secondary to numerous disease processes, can result in reduced vision as a result of oedema, haemorrhage, and scarring ...
Vikas Tah, Harry O. Orlans, Jonathan Hyer, Edward Casswell, Nizar Din, Vishnu Sri Shanmuganathan, Louise Ramskold, Saruban Pasu   +7 more
doaj   +1 more source

IL-17A Damages the Blood–Retinal Barrier through Activating the Janus Kinase 1 Pathway

Biomedicines, 2021
Blood–retinal barrier (BRB) dysfunction underlies macular oedema in many sight-threatening conditions, including diabetic macular oedema, neovascular age-related macular degeneration and uveoretinitis.
Eimear M. Byrne, María Llorián-Salvador, Miao Tang, Andriana Margariti, Mei Chen, Heping Xu   +5 more
doaj   +1 more source

Intravitreal Ranibizumab for Diabetic Macular Oedema [PDF]

European Ophthalmic Review, 2015
Diabetic macular oedema (DMO) is the most frequent cause of vision loss in patients affected by diabetes mellitus, and has a remarkable effect on public health. The treatment with focal/grid laser photocoagulation was considered in the past decades as the standard of care, but the recent advent of new pharmacological approaches, based on the use of ...
Maurizio Battaglia Parodi, Maria Vittoria Cicinelli, Francesco Bandello   +2 more
openaire   +1 more source

Microelectromechanical system‐based devices for the diagnosis, treatment, and monitoring of ophthalmic diseases

Interdisciplinary Medicine, EarlyView.
Due to the characteristics of miniaturization, high sensing performance, integration, and high comfort, MEMS‐based devices were employed to design sensors, imaging systems, drug delivery systems, retinal prosthesis, surgical tools, and wearable products for the ophthalmic disease diagnosis, treatment, and monitoring.
Yaling Peng, Xiaoming Huang, Xueyuan Zhang, Yiling Jiang, Xin Zhang, Xueying Zeng, Fengyuan Sun, Peng Liu, Jin Zhou, Zewei Luo, Tong Wu   +10 more
wiley   +1 more source